Currently out of the existing stock ratings of Alex Arfaei, 84 are a BUY (58.33%), 46 are a HOLD (31.94%), 14 are a SELL (9.72%).

Alex Arfaei

Work Performance Price Targets & Ratings Chart

Analyst Alex Arfaei, carries an average stock price target met ratio of 94.55% that have a potential upside of 48.75% achieved within 652 days. Previously, Alex Arfaei worked at BMO.

Alex Arfaei’s has documented 287 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on PFE, Pfizer at 08-May-2019.

Wall Street Analyst Alex Arfaei

Analyst best performing recommendations are on KIN (KINDRED BIOSCIENCES).
The best stock recommendation documented was for KIN (KINDRED BIOSCIENCES) at 11/15/2015. The price target of $5 was fulfilled within 1 day with a profit of $0.47 (8.59%) receiving and performance score of 85.92.

Average potential price target upside

ABBV AbbVie BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer AZN AstraZeneca PLC ADR KIN Kindred Biosciences ZTS Zoetis ELAN Elanco Animal Health

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Feb-2020

$288

$2.58 (0.90%)

$288

9 days ago
(09-Oct-2026)

43/45 (95.56%)

$11.53 (4.17%)

424

Hold Since 07-Jan-2026

$275

$-10.42 (-3.65%)

$260

9 days ago
(09-Oct-2026)

5/5 (100%)

$-1.47 (-0.53%)

76

Buy Since 16-Oct-2020

$300

$14.58 (5.11%)

$280

10 days ago
(08-Oct-2026)

20/21 (95.24%)

$27.58 (10.12%)

441

Buy Since 16-Nov-2023

$290

$4.58 (1.60%)

$285

10 days ago
(08-Oct-2026)

31/32 (96.88%)

$17.58 (6.45%)

251

Buy Since 06-Apr-2022

$310

$24.58 (8.61%)

$278

11 days ago
(07-Oct-2026)

33/34 (97.06%)

$38.64 (14.24%)

486

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?